• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Insulet

Report: Dexcom in talks to acquire Insulet

May 23, 2022 By Sean Whooley

Major players in the diabetes space could join forces as Dexcom (Nasdaq:DXCM) is reportedly in discussions to acquire Insulet (Nasdaq:PODD). Bloomberg reported today that people “with knowledge of the matter” have said talks are ongoing over a potential acquisition and even said an agreement could be reached “in the coming weeks.” Bloomberg’s sources preferred to remain anonymous […]

Filed Under: Business/Financial News, Diabetes, Drug Pumps, Drug-Device Combinations, Featured, Mergers & Acquisitions, Patient Monitoring Tagged With: Dexcom, Insulet

Here’s what’s next for Insulet after the launch of Omnipod 5, CEO change

May 12, 2022 By Sean Whooley

The future for Insulet (Nasdaq:PODD) has a different look than it did about a week ago. A massive shake-up at the executive level came on May 5 when Shacey Petrovic announced she would step down as president and CEO for personal reasons. Petrovic will stay on as a board member at the Acton, Massachusetts-based automated insulin […]

Filed Under: Business/Financial News, Diabetes, Drug Pumps, Drug-Device Combinations, Featured, Patient Monitoring, Pharmaceutical Tagged With: DeviceTalks Boston, Insulet, Personnel Moves

Shacey Petrovic to step down as Insulet CEO, ResMed exec Jim Hollingshead to take role

May 5, 2022 By Sean Whooley

Insulet (Nasdaq:PODD) announced today that President and CEO Shacey Petrovic will step down for personal family reasons. Petrovic will step down from her position effective June 1, 2022, but will continue to serve on the company’s board. She will also serve as an advisor to the company through May 2023 to support the leadership transition to […]

Filed Under: Business/Financial News, Diabetes, Drug Pumps, Drug-Device Combinations, Featured Tagged With: Insulet, Personnel Moves

Insulet posts Street-beating Q1 as Omnipod 5 rollout is ‘progressing very well’

May 5, 2022 By Sean Whooley

Insulet (Nasdaq:PODD) shares were down after hours despite first-quarter results that topped the consensus forecast. The Acton, Massachusetts-based automated insulin technology developer posted profits of $27.8 million, or 40¢ per share, on sales of $295.4 million for the three months ended March 31, 2022, for a big bottom-line gain from breakeven this time a year ago […]

Filed Under: Business/Financial News, Diabetes, Drug Pumps, Drug-Device Combinations, Featured, MassDevice Earnings Roundup, Wall Street Beat Tagged With: Insulet

CGMs, insulin pumps and more: the biggest diabetes news to come out of ATTD 2022

May 3, 2022 By Sean Whooley

All kinds of technologies were on display at the Advanced Technologies & Treatments for Diabetes (ATTD) conference in Barcelona last week. From continuous glucose monitoring (CGM) to automated insulin delivery, with plenty in between, a number of companies shared positive data for their diabetes offerings. Here are five of the biggest stories to come out […]

Filed Under: Business/Financial News, Clinical Trials, Diabetes, Digital Health, Drug Pumps, Drug-Device Combinations, Featured, Health Technology, Patient Monitoring, Software / IT Tagged With: Abbott, Ascensia Diabetes Care, Beta Bionics, CamDiab, DarioHealth Corp, Dexcom, Diabeloop, Insulet, Medtronic, One Drop, Tandem Diabetes Care, Walmart, Welldoc, Ypsomed

Insulet announces positive study data for Omnipod 5 for type 1, type 2 diabetes

April 27, 2022 By Sean Whooley

Insulet (Nasdaq:PODD) today unveiled study results for the new Omnipod 5 automated insulin delivery system in type 1 and type 2 diabetes. Acton, Massachusetts-based Insulet presented results from studies as well as user experience data for both type 1 and type 2 diabetes at the Advanced Technologies & Treatments for Diabetes (ATTD) conference in Barcelona, Spain. […]

Filed Under: Business/Financial News, Clinical Trials, Diabetes, Drug Pumps, Drug-Device Combinations, Featured, Patient Monitoring Tagged With: Insulet

How Insulet created its next-gen Omnipod 5

April 19, 2022 By Sean Whooley

Insulet (NSDQ:PODD) added to its portfolio of life-changing diabetes management technologies when its Omnipod 5 received FDA clearance in January. Omnipod 5 provides easier glucose management, with no multiple daily injections, no tubes and zero fingersticks. Paired with Dexcom’s G6 continuous glucose monitoring (CGM) system, Omnipod 5 is the first tubeless, wearable, automated insulin delivery […]

Filed Under: Business/Financial News, Diabetes, Drug Pumps, Drug-Device Combinations, Featured, Health Technology, Software / IT Tagged With: DeviceTalks Boston, Insulet

Diabetes tech is off to a hot start in 2022

March 16, 2022 By Sean Whooley

Diabetes technology developers have high hopes for the year ahead, some of which have already come to fruition. Change is continuous in continuous glucose monitoring (GCM), with expanded wear-times, improved accuracy and more. Meanwhile, never-ending innovation in insulin delivery is delivering wearable patches and closedloop delivery systems, making insulin management easier for people with diabetes. […]

Filed Under: Business/Financial News, Diabetes, Drug Pumps, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Health Technology, Patient Monitoring, Regulatory/Compliance, Software / IT Tagged With: Bigfoot Biomedical, Dexcom, FDA, Insulet, Senseonics, Tandem Diabetes Care

Insulet posts Street-beating Q4 with Omnipod revenues up nearly 20% from 2020

February 23, 2022 By Sean Whooley

Insulet (NSDQ:PODD) this evening reported fourth-quarter results that came in ahead of the Wall Street consensus forecast amid strong sales growth. The Acton, Massachusetts–based maker of Omnipod insulin delivery systems posted profits of $29.2 million, or 42¢ per share, on sales of $307.7 million for the three months ended Dec. 31, 2021, for a massive […]

Filed Under: Business/Financial News, Diabetes, Drug Pumps, Drug-Device Combinations, Featured, MassDevice Earnings Roundup, News Well, Wall Street Beat Tagged With: Insulet

Insulet, Nintendo use ‘Animal Crossing’ video game to promote inclusivity for diabetes community

February 17, 2022 By Sean Whooley

Insulet (NSDQ:PODD) announced today that new features set to debut on Nintendo’s Animal Crossing video game are inspired by people with diabetes. Acton, Massachusetts-based Insulet aims to promote representation and inclusion for the diabetes community through an activation on Animal Crossing: New Horizons. Get the full story at our sister site, Drug Delivery Business News.

Filed Under: Business/Financial News, Diabetes, Drug Pumps, Drug-Device Combinations, Featured Tagged With: Insulet

Insulet appoints Elizabeth Weatherman to board of directors

February 9, 2022 By Sean Whooley

Insulet (NSDQ:PODD) announced that Elizabeth (Bess) Weatherman was appointed to its board of directors. Weatherman — a veteran dealmaker in the health technology space — will stand for election by stockholders at the company’s 2022 annual meeting and has been named to the board’s Compensation Committee. Get the full story at our sister site, Drug Delivery […]

Filed Under: Business/Financial News, Diabetes, Drug Pumps, Drug-Device Combinations Tagged With: Insulet, Personnel Moves

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 22
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

May 27, 2022
Quick message - No DTW podcast, but plenty else to listen to over this weekend and next week.
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS